|
1
|
Isaacson P and Wright DH: Malignant
lymphoma of mucosa-associated lymphoid tissue. A distinctive type
of B-cell lymphoma. Cancer. 52:1410–1416. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harris N, Jaffe E, Stein H, et al: A
revised European-American classification of lymphoid neoplasm: a
proposal from the International Lymphoma Study Group. Blood.
84:1361–1392. 1994.PubMed/NCBI
|
|
3
|
Cadranel J, Wislez M and Antoine M:
Primary pulmonary lymphoma. Eur Respir J. 20:750–762. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Klein TO, Soll BA, Issel BF, et al:
Bronchus-associated lymphoid tissue lymphoma and Mycobacterium
Tuberculosis infection: an unusual case and a review of the
literature. Respir Care. 52:755–758. 2007.PubMed/NCBI
|
|
5
|
Borie R, Wislez M, Thabut G, et al:
Clinical characteristics and prognostic factors of pulmonary MALT
lymphoma. Eur Respir J. 34:1408–1416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu HY, Jin T, Li RY, et al: Diagnosis and
treatment of pulmonary mucosa-associated lymphoid tissue lymphoma.
Chin Med J. 20:648–651. 2007.
|
|
7
|
Bae YA, Lee KS, Han J, et al: Marginal
zone B-cell lymphoma of bronchus-associated lymphoid tissue:
imaging findings in 21 patients. Chest. 133:433–440. 2008.
View Article : Google Scholar
|
|
8
|
Kurtin PJ, Myers JL, Adlakha H, et al:
Pathologic and clinical features of primary pulmonary extranodal
marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol.
25:997–1008. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lazar EB, Whitman GJ and Chew FS: Lymphoma
of bronchus-associated lymphoid tissue. AJR Am J Roentgenol.
167:1161996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boulanger E, Meignin V, Baia M, et al:
Mucosa-associated lymphoid tissue lymphoma in patients with human
immunodeficiency virus infection. Br J Haematol. 140:470–474. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahmed S, Kussick SJ, Siddiqui AK, et al:
Bronchial-associated lymphoid tissue lymphoma: a clinical study of
a rare disease. Eur J Cancer. 40:1320–1326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zinzani PL, Pellegrini C, Gandolfi L, et
al: Extranodal marginal zone B-cell lymphoma of the lung:
experience with fludarabine and mitoxantrone-containing regimens.
Hematol Oncol. 31:183–188. 2013. View
Article : Google Scholar
|
|
13
|
Jäger G, Neumeister P, Quehenberger F, et
al: Prolonged clinical remission in patients with extranodal
marginal zone B-cell lymphoma of the mucosa-associated lymphoid
tissue type treated with cladribine: 6 year follow-up of phase II
trial. Ann Oncol. 11:1722–1723. 2006. View Article : Google Scholar
|
|
14
|
Troch M, Streubel B, Petkov V, et al: Does
MALT lymphoma of the lung require immediate treatment? An analysis
of 11 untreated cases with long-term follow-up. Anticancer Res.
27:3633–3637. 2007.PubMed/NCBI
|
|
15
|
Ferraro P, Trastek VF, Adlakha H, et al:
Primary non-Hodgkin’s lymphoma of the lung. Ann Thorac Surg.
69:933–937. 2000. View Article : Google Scholar
|
|
16
|
Oh SY, Kim WS, Kim JS, et al: Pulmonary
marginal zone B-cell lymphoma of MALT type - what is a prognostic
factor and which is the optimal treatment, operation, or
chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL)
study. Ann Hematol. 89:563–568. 2010. View Article : Google Scholar
|
|
17
|
Conconi A, Martinelli G, Thiéblemont C, et
al: Clinical activity of rituximab in extranodal marginal zone
B-cell lymphoma of MALT type. Blood. 102:2741–2745. 2003.
View Article : Google Scholar : PubMed/NCBI
|
